A comparison of tumour perfusion assessed by deconvolution-based analysis of dynamic contrast-enhanced CT and MR imaging in patients with squamous cell carcinoma of the upper aerodigestive tract

European Radiology

Volumn 18, Issue 4, 2008, Pages 843-850

  Bisdas, Sotirios ^a   Medov, Leon ^a   Baghi, Mehran ^a   Konstantinou, George N ^b   Wagenblast, Jens ^a   Thng, Choon Hua ^c   Vogl, Thomas J ^a   Koh, Tong San ^d  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b 401 Military Hospital   (Greece)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^d NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Deconvolution analysis; PerfusionCT; Squamous cell carcinoma; T2 MR imaging

Indexed keywords

GADOLINIUM PENTETATE; IOMEPROL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; SQUAMOUS CELL CARCINOMA; UPPER AERODIGESTIVE TRACT CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CONTRAST MEDIA; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41349083774     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-007-0827-3     Document Type: Article

References (25)

1. Bisdas S, Baghi M, Smolarz A et al (2007) Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography studies. Invest Radiol 42:172-179
2. Lankester KJ, Taylor JN, Stirling JJ et al (2007) Dynamic MRI for imaging tumor microvasculature: Comparison of susceptibility and relaxivity techniques in pelvic tumors. J Magn Reson Imaging 25:796-805
3. Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz WJ (1994) Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 193:637-641
4. Bland JM, Altman DG (1995) Comparing methods of measurement: Why plotting difference against standard method is misleading. Lancet 346:1085-1087
5. Bland JM, Altman DG (2003) Applying the right statistics: Analyses of measurement studies. Ultrasound Obstet Gynecol 22:85-93
6. Gandhi D, Hoeffner EG, Carlos RC, Case I, Mukherji SK (2003) Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract. Initial results. J Comput Assist Tomogr 27:687-693
7. Rumboldt Z, Al-Okaili R, Deveikis JP (2005) Perfusion CT for head and neck tumors: Pilot study. AJNR Am J Neuroradiol 26:1178-1185
8. Hermans R, Lambin P, Van der Goten A et al (1999) Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. Radiother Oncol 53:105-111
9. Gandhi D, Chepeha DB, Miller T et al (2006) Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol 27:101-106
10. Zima A, Carlos R, Gandhi D, Case I, Teknos T, Mukherji SK (2007) Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? AJNR Am J Neuroradiol 28:328-334
11. Hermans R, Meijerink M, Van den Bogaert W, Rijnders A, Weltens C, Lambin P (2003) Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 57:1351-1356
12. Wintermark M, Maeder P, Verdun FR et al (2000) Using 80 kVp versus 120 kVp in perfusion CT measurement of regional cerebral blood flow. AJNR Am J Neuroradiol 21:1881-1884
13. Kuperman VY, Alley MT (1999) Differentiation between the effects of T1 and T2* shortening in contrast-enhanced MRI of the breast. J Magn Reson Imaging 9:172-176
14. Uematsu H, Maeda M (2006) Double-echo perfusion-weighted MR imaging: basic concepts and application in brain tumors for the assessment of tumor blood volume and vascular permeability. Eur Radiol 16:180-186
15. de Bazelaire C, Rofsky NM, Duhamel G et al (2006) Combined T2* and T1 measurements for improved perfusion and permeability studies in high field using dynamic contrast enhancement. Eur Radiol 16:2083-2091
16. Ellinger R, Kremser C, Schocke MF et al (2000) The impact of peak saturation of the arterial input function on quantitative evaluation of dynamic susceptibility contrast-enhanced MR studies. J Comput Assist Tomogr 24:942-948
17. Asaumi J, Yanagi Y, Hisatomi M, Matsuzaki H, Konouchi H, Kishi K (2003) The value of dynamic contrast-enhanced MRI in diagnosis of malignant lymphoma of the head and neck. Eur J Radiol 48:183-187
18. Baba Y, Furusawa M, Murakami R et al (1997) Role of dynamic MRI in the evaluation of head and neck cancers treated with radiation therapy. Int J Radiat Oncol Biol Phys 37:783-787
19. Baba Y, Yamashita Y, Onomichi M, Murakami R, Takahashi M (1999) Dynamic magnetic resonance imaging of head and neck lesions. Top Magn Reson Imaging 10:125-129
20. Guckel C, Schnabel K, Deimling M, Steinbrich W (1996) Dynamic snapshot gradient-echo imaging of head and neck malignancies: Time dependency and quality of contrast-to-noise ratio. Magma 4:61-69
21. Hoskin PJ, Saunders MI, Goodchild K, Powell ME, Taylor NJ, Baddeley H (1999) Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. Br J Radiol 72:1093-1098
22. Escott EJ, Rao VM, Ko WD, Guitierrez JE (1997) Comparison of dynamic contrast-enhanced gradient-echo and spin-echo sequences in MR of head and neck neoplasms. AJNR Am J Neuroradiol 18:1411-1419
23. Galbraith SM, Lodge MA, Taylor NJ et al (2002) Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: Comparison of quantitative and semi-quantitative analysis. NMR Biomed 15:132-142
24. Jackson A, Kassner A, Annesley-Williams D, Reid H, Zhu XP, Li KL (2002) Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: Comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol 23:7-14
25. Essig M, Wenz F, Scholdei R et al (2002) Dynamic susceptibility contrast-enhanced echo-planar imaging of cerebral gliomas. Effect of contrast medium extravasation. Acta Radiol 43:354-359